(Q39817718)

14 September 2017

In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria (English)

1 reference

14 September 2017

gram-positive bacteria

0 references

antibiotic

0 references

author name string

Debbia E

series ordinal

1

1 reference

14 September 2017

Pesce A

series ordinal

2

1 reference

14 September 2017

Schito GC

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 February 1988

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 September 2017

32

1 reference

14 September 2017

2

1 reference

14 September 2017

279-281

1 reference

Antibiotic synergism and antimicrobial combinations in clinical infections

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

Combination antibiotic therapy of bacterial endocarditis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

In vitro activity of LY146032 against staphylococci, streptococci, and enterococci

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

In vitro activity of teichomycin and vancomycin alone and in combination with rifampin

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172154

Problems in determination of antibiotic synergism in vitro

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2834999

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.32.2.279

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

2834999

1 reference